FCPM III SERVICES B.V. Long-Term Concentrated

Location: Naarden, Netherlands

CIK: 0002013410 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value: $369M (100.0% shares, 0.0% debt)

Holdings (8)

NAMS NEWAMSTERDAM PHARMA COMPANY 52.2%

Value $193M Shares 10,632,113 Est. Cost $9.56 Unrealized +90.7%

DYN DYNE THERAPEUTICS INC 14.1%

Value $52.01M Shares 5,462,846 Est. Cost $12.58 Unrealized -12.5%

REPL REPLIMUNE GROUP INC 9.8%

Value $36.32M Shares 3,909,696 Est. Cost $11.59 Unrealized -24.7%

ENGN ENGENE HOLDINGS INC 9.5%

Value $35.06M Shares 9,632,561 Est. Cost $10.14 Unrealized -63.0%

BCYC BICYCLE THERAPEUTICS PLC 6.5%

Value $23.99M Shares 3,452,330 Est. Cost $18.38 Unrealized —

— ASTRIA THERAPEUTICS INC 6.3%

Value $23.41M Shares 4,107,537 Est. Cost $7.88 Unrealized —

RAPT RAPT THERAPEUTICS INC 0.9%

Value $3.451M Shares 440,176 Est. Cost $7.63 Unrealized 0.0%

ENGNW ENGENE HOLDINGS INC 0.6%

Value $2.36M Shares 2,878,148 Est. Cost $0.63 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
NAMS	NEWAMSTERDAM PHARMA COMPANY	10,632,113	$193M	52.2%	$9.56	+90.7%	ORDINARY SHARES	N62509109
DYN	DYNE THERAPEUTICS INC	5,462,846	$52.01M	14.1%	$12.58	-12.5%	COM	26818M108
REPL	REPLIMUNE GROUP INC	3,909,696	$36.32M	9.8%	$11.59	-24.7%	COM	76029N106
ENGN	ENGENE HOLDINGS INC	9,632,561	$35.06M	9.5%	$10.14	-63.0%	COM	29286M105
BCYC	BICYCLE THERAPEUTICS PLC	3,452,330	$23.99M	6.5%	$18.38	—	SPONSORED ADS	088786108
—	ASTRIA THERAPEUTICS INC	4,107,537	$23.41M	6.3%	$7.88	—	COM	04635X102
RAPT	RAPT THERAPEUTICS INC	440,176	$3.451M	0.9%	$7.63	0.0%	COM NEW	75382E208
ENGNW	ENGENE HOLDINGS INC	2,878,148	$2.36M	0.6%	$0.63	—	W EXP 10/31/2028	29286M113